Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India
- 31 October 2004
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 33 (2) , 153-157
- https://doi.org/10.1016/j.bcmd.2004.05.002
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- β-THALASSEMIA INTERMEDIA FROM SOUTHERN IRAN: IVS-II-1 (G→A) IS THE PREVALENT THALASSEMIA INTERMEDIA ALLELEHemoglobin, 2002
- A NOVEL β0-THALASSEMIA MUTATION AT CODON 55 (−A) AND A RARE 17 bp DELETION AT CODONS 126–131 IN THE INDIAN POPULATIONHemoglobin, 2002
- Molecular analysis of β-thalassaemia patients in a high incidence area of southern ItalyClinical and Laboratory Haematology, 2001
- β-Thalassaemia intermedia in LebanonEuropean Journal of Haematology, 2000
- Potential of denaturing gradient gel electrophoresis for scanning of ?-thalassemia mutations in IndiaAmerican Journal of Hematology, 1999
- Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?British Journal of Haematology, 1998
- Genetic analysis of β-thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotypeAmerican Journal of Hematology, 1997
- Rare β‐thalassaemia mutations in Asian IndiansBritish Journal of Haematology, 1991
- The spectrum of β‐thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosisBritish Journal of Haematology, 1991
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977